Ubs Group Ag United Therapeutics Corp Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025

A detailed history of Ubs Group Ag transactions in United Therapeutics Corp stock. As of the latest transaction made, Ubs Group Ag holds 104,114 shares of UTHR stock, worth $46.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
104,114
Previous 133,317 21.9%
Holding current value
$46.7 Million
Previous $41.1 Million 27.2%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$276.47 - $328.4 $8.07 Million - $9.59 Million
-29,203 Reduced 21.9%
104,114 $29.9 Million
Q1 2025

May 13, 2025
BUY
$304.42 - $380.78 $11.6 Million - $14.6 Million
38,251 Added 40.24%
133,317 $41.1 Million
Q4 2024

Feb 14, 2025
SELL
$348.66 - $410.0 $1.42 Million - $1.67 Million
-4,071 Reduced 4.11%
95,066 $33.5 Million
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $5.4 Million - $6.31 Million
17,361 Added 21.23%
99,137 $35.5 Million
Q2 2024

Aug 13, 2024
BUY
$228.26 - $319.04 $488,248 - $682,426
2,139 Added 2.69%
81,776 $26 Million
Q1 2024

May 13, 2024
BUY
$210.76 - $249.51 $3.15 Million - $3.73 Million
14,963 Added 23.14%
79,637 $18.3 Million
Q4 2023

Feb 09, 2024
BUY
$214.88 - $256.94 $1.51 Million - $1.8 Million
7,020 Added 12.18%
64,674 $14.2 Million
Q3 2023

Nov 09, 2023
SELL
$211.82 - $248.24 $525,525 - $615,883
-2,481 Reduced 4.13%
57,654 $13 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $1.34 Million - $1.52 Million
-6,544 Reduced 9.81%
60,135 $13.3 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $2.49 Million - $3.23 Million
11,679 Added 21.23%
66,679 $14.9 Million
Q4 2022

Feb 08, 2023
BUY
$205.95 - $280.43 $2.66 Million - $3.62 Million
12,901 Added 30.64%
55,000 $15.3 Million
Q3 2022

Nov 10, 2022
SELL
$203.3 - $244.17 $5.22 Million - $6.27 Million
-25,694 Reduced 37.9%
42,099 $8.82 Million
Q2 2022

Aug 10, 2022
BUY
$174.81 - $241.14 $2.46 Million - $3.4 Million
14,087 Added 26.23%
67,793 $16 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $5.27 Million - $6.79 Million
-31,733 Reduced 37.14%
53,706 $9.64 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $7.33 Million - $8.6 Million
39,794 Added 87.18%
85,439 $18.5 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $11.8 Million - $14.1 Million
-65,778 Reduced 59.03%
45,645 $8.43 Million
Q2 2021

Aug 13, 2021
BUY
$170.47 - $211.93 $11.7 Million - $14.6 Million
68,746 Added 161.08%
111,423 $20 Million
Q1 2021

May 12, 2021
BUY
$153.94 - $174.85 $3.47 Million - $3.94 Million
22,510 Added 111.62%
42,677 $7.14 Million
Q4 2020

Feb 11, 2021
SELL
$101.87 - $151.79 $3.89 Million - $5.8 Million
-38,234 Reduced 65.47%
20,167 $3.06 Million
Q3 2020

Nov 12, 2020
BUY
$99.9 - $121.13 $1.9 Million - $2.3 Million
18,981 Added 48.15%
58,401 $5.9 Million
Q2 2020

Jul 31, 2020
BUY
$92.74 - $125.82 $3.55 Million - $4.82 Million
38,308 Added 3444.96%
39,420 $4.77 Million
Q1 2020

May 01, 2020
SELL
$79.39 - $115.35 $111,463 - $161,951
-1,404 Reduced 55.8%
1,112 $106,000
Q4 2019

Feb 14, 2020
SELL
$78.31 - $95.34 $4.27 Million - $5.2 Million
-54,558 Reduced 95.59%
2,516 $221,000
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $3.87 Million - $4.44 Million
51,670 Added 956.14%
57,074 $4.55 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $6.38 Million - $10.1 Million
-83,944 Reduced 93.95%
5,404 $422,000
Q1 2019

May 14, 2019
SELL
$107.15 - $126.84 $2.41 Million - $2.85 Million
-22,504 Reduced 20.12%
89,348 $10.5 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $9.57 Million - $12.1 Million
94,367 Added 539.7%
111,852 $12.2 Million
Q3 2018

Nov 14, 2018
BUY
$113.81 - $129.46 $1.58 Million - $1.8 Million
13,914 Added 389.64%
17,485 $2.24 Million
Q2 2018

Aug 14, 2018
SELL
$101.14 - $118.31 $5.53 Million - $6.46 Million
-54,630 Reduced 93.86%
3,571 $404,000
Q1 2018

May 15, 2018
BUY
$107.21 - $151.94 $5.48 Million - $7.76 Million
51,092 Added 718.69%
58,201 $6.54 Million
Q4 2017

Feb 14, 2018
SELL
$118.58 - $151.28 $1.35 Million - $1.72 Million
-11,369 Reduced 61.53%
7,109 $1.05 Million
Q3 2017

Nov 14, 2017
SELL
$114.6 - $136.81 $213,385 - $254,740
-1,862 Reduced 9.15%
18,478 $2.17 Million
Q2 2017

Aug 14, 2017
SELL
N/A
-9,088 Reduced 30.88%
20,340 $2.64 Million
Q1 2017

Nov 14, 2017
BUY
N/A
29,428
29,428 $3.98 Million

Others Institutions Holding UTHR

# of Institutions
746
Shares Held
44.1M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $20.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email